A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor

Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.

We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.

We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.

Definition medical devices.

Medical Device Industry News | Latest Developments, Breakthroughs & Future Outlook

Latest News and Developments

Ellipsys Vascular Access System to Return to U.S. Market in 2026

Ellipsys Vascular Access System to Return to U.S. Market in 2026

Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial availability anticipated in mid-2026. The announcement marks the planned reintroduction of the minimally invasive technology to clinicians and patients following a period of limited market availability. The Ellipsys System, previously available...

Clinical Trials

Biotechnology News

Mergers & Acquisitions

Funding

Conformal Medical

Conformal Medical Raises $35 Million in Oversubscribed Series D Round

The highly supported round reflects the progress and achievements made since its last funding round, which includes the initiation of the CONFORM Clinical Trial. The CONFORM Trial is the company’s pivotal trial evaluating the safety and efficacy of the CLAAS® System compared to other commercially available LAAO devices and will support U.S. Food and Drug Administration (FDA) pre-market approval.

PathMaker Neurosystems Receives $200,000 START Award from MassVentures

“We are grateful for the Stage 2 award from MassVentures as we work to bring MyoRegulator® to market,” said Nader Yaghoubi, M.D., Ph.D., Co-Founder and Chief Executive Officer of PathMaker. “As we continue our US multi-center pivotal trial in post-stroke spasticity and work to launch our first clinical trial in ALS this year, MassVentures support for late-stage development of our product is greatly appreciated.”

Industry Expert Bylines

RTS Tactical Rapid Deploy IFAK By Mendel Berns

RTS Tactical Rapid Deploy IFAK By Mendel Berns

Mendel Berns writes, “When treating an injury in the field, time is critical. Every second counts. You need to be ready when called upon to save the life of a team member or perhaps your own.” Read what he has to say about having the best medical equipment.

FDA Medical Device Updates

Market Reports

Executives

Advancements In Imaging

Hospitals In the News

Non-Profit News

Healthcare: Understanding the Business Side of the Industry and Its Implications

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.